ORLY
60
-5
DG
8
-2
FAST
57
-3
DLTR
38
-4
C
62
4
AAPL
40
-6
HCP
56
-8
TSN
50
-2
LLY
28
-8
EOG
56
-2
XOM
42
-6
IPG
34
-9
THC
60
-5
URI
60
-6
USB
50
-3
PEG
62
4
ADSK
66
-4
ADP
65
-3
PAYX
48
-6
COP
57
-2
ORLY
60
-5
DG
8
-2
FAST
57
-3
DLTR
38
-4
C
62
4
AAPL
40
-6
HCP
56
-8
TSN
50
-2
LLY
28
-8
EOG
56
-2
XOM
42
-6
IPG
34
-9
THC
60
-5
URI
60
-6
USB
50
-3
PEG
62
4
ADSK
66
-4
ADP
65
-3
PAYX
48
-6
COP
57
-2
Financhill
Back

ERShares Private-Public Crossover ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
62

XOVR
ERShares Private-Public Crossover ETF

Last Price:
17.45
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Buy
62
ERShares Private-Public Crossover ETF (XOVR) is a Buy

Is ERShares Private-Public Crossover ETF a Buy, Sell or Hold?

  • The current ERShares Private-Public Crossover ETF [XOVR] share price is $17.51. The Score for XOVR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • XOVR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XOVR Stock Price Chart

What is ERShares Private-Public Crossover ETF's stock price today?

  • The ERShares Private-Public Crossover ETF share price today is $17.51
    The current trend is relatively stagnant and XOVR is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $42.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

XOVR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.24 Buy
Relative Strength Index (14 RSI): 58.7 Buy
Chaikin Money Flow: 5593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.37 - 17.59) Buy
Bollinger Bands (100): ( - ) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 26.84 Sell
Chaikin Money Flow: -3822578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.96 - 58.72) Sell
Bollinger Bands (100): (51.86 - 60.48) Sell

XOVR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.79 Sell
20-day SMA: 17.06 Buy
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 17.55 Sell
20-day EMA: 16.82 Buy
50-day EMA: 13.11 Buy
200-day EMA: 5.2 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.27 Sell
20-day SMA: 54.02 Sell
50-day SMA: 55.85 Sell
200-day SMA: 48.97 Sell
8-day EMA: 52.24 Sell
20-day EMA: 54.19 Sell
50-day EMA: 55.13 Sell
200-day EMA: 50.65 Sell

ERShares Private-Public Crossover ETF Earnings Growth & XOVR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

ERShares Private-Public Crossover ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):